Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Sales | 29,053 | 32,713 | 61,280 | 55,286 | 23,795 |
| Cost of Goods | 911 | 1,599 | 13,128 | 8,966 | 2,057 |
| Gross Profit | 28,142 | 31,114 | 48,152 | 46,320 | 21,738 |
| Operating Expenses | 1,032,347 | -4,465,319 | 1,223,598 | 1,398,928 | 1,092,693 |
| Operating Income | -1,003,294 | 4,497,032 | -1,175,318 | -1,351,642 | -1,070,898 |
| Interest Expense | 0 | 0 | 27,968 | 7,041 | 0 |
| Other Income | 321,704 | 70,824 | -21,548 | 434,936 | 172,351 |
| Pre-tax Income | -681,590 | 4,567,856 | -1,224,834 | -923,747 | -898,547 |
| Income Tax | 48,174 | 21,503 | 5,190 | 369 | 1,686 |
| Net Income Continuous | -729,764 | 4,546,353 | -1,230,024 | -924,116 | -900,233 |
| Net Income Discontinuous | 373,030 | -315,147 | 114,561 | N/A | N/A |
| Minority Interests | -184,753 | -117,720 | -106,433 | -78,854 | -90,999 |
| Net Income | $-171,981 | $4,348,926 | $-1,009,030 | $-845,262 | $-809,234 |
| EPS Basic Total Ops | -0.24 | 5.55 | -1.42 | -1.26 | -1.28 |
| EPS Basic Continuous Ops | -1.01 | 5.80 | -1.73 | -1.38 | -1.43 |
| EPS Basic Discontinuous Ops | 0.51 | -0.40 | 0.16 | N/A | N/A |
| EPS Diluted Total Ops | -0.24 | 5.23 | -1.42 | -1.26 | -1.28 |
| EPS Diluted Continuous Ops | -1.01 | 5.47 | -1.73 | -1.38 | -1.43 |
| EPS Diluted Discontinuous Ops | 0.51 | -0.38 | 0.16 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -1.17 | -1.15 | -1.58 | -1.26 | N/A |
| EBITDA(a) | $-989,223 | $4,519,068 | $-1,156,461 | $-1,345,710 | $-1,070,898 |